Hookipa Pharma Stock Beneish M Score

HOOK Stock  USD 0.85  0.08  10.39%   
This module uses fundamental data of Hookipa Pharma to approximate the value of its Beneish M Score. Hookipa Pharma M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Hookipa Pharma Piotroski F Score and Hookipa Pharma Altman Z Score analysis.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.
  
At this time, Hookipa Pharma's Debt Ratio is quite stable compared to the past year. At this time, Hookipa Pharma's EV To Free Cash Flow is quite stable compared to the past year. Net Debt To EBITDA is expected to rise to 2.50 this year, although the value of Days Sales Outstanding will most likely fall to 299.96.
At this time, it appears that Hookipa Pharma is an unlikely manipulator. The earnings manipulation may begin if Hookipa Pharma's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Hookipa Pharma executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Hookipa Pharma's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-5.92
Beneish M Score - Unlikely Manipulator
Elasticity of Receivables

1.18

Focus
Asset Quality

-4.07

Focus
Expense Coverage

1.18

Focus
Gross Margin Strengs

1.04

Focus
Accruals Factor

1.18

Focus
Depreciation Resistance

0.8

Focus
Net Sales Growth

0.72

Focus
Financial Leverage Condition

1.46

Focus

Hookipa Pharma Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Hookipa Pharma's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables16.4 M19.3 M
Fairly Down
Slightly volatile
Total Assets146.4 M161.3 M
Moderately Down
Slightly volatile
Total Current Assets130.2 M147.1 M
Fairly Down
Slightly volatile
Non Current Assets Total16.2 M14.2 M
Fairly Up
Slightly volatile
Property Plant Equipment13 M20.7 M
Way Down
Slightly volatile
Depreciation And Amortization2.9 M3.6 M
Significantly Down
Slightly volatile
Selling General Administrative15.8 M18.6 M
Fairly Down
Slightly volatile
Total Current Liabilities25.1 M42 M
Way Down
Slightly volatile
Non Current Liabilities Total24.4 M29.5 M
Significantly Down
Slightly volatile
Short Term Debt3.2 M2.8 M
Fairly Up
Slightly volatile
Long Term Debt778.9 K819.9 K
Notably Down
Slightly volatile

Hookipa Pharma Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Hookipa Pharma's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Hookipa Pharma in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Hookipa Pharma's degree of accounting gimmicks and manipulations.

About Hookipa Pharma Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation And Amortization

2.9 Million

At this time, Hookipa Pharma's Depreciation And Amortization is quite stable compared to the past year.

Hookipa Pharma Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Hookipa Pharma. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables9.7M20.7M21.2M22.0M19.3M16.4M
Total Revenue11.9M19.6M18.4M14.2M20.1M14.5M
Total Assets143.7M187.8M126.0M170.5M161.3M146.4M
Total Current Assets128.0M171.5M102.1M147.2M147.1M130.2M
Net Debt(102.6M)(132.7M)(56.3M)(106.9M)(110.5M)(116.1M)
Long Term Debt3.5M4.5M2.2M911K819.9K778.9K
Operating Income(51.1M)(53.3M)(81.7M)(73.2M)(84.9M)(89.2M)
Investments(2.0M)(2.4M)(12.6M)(5.0M)(4.3M)(4.6M)

About Hookipa Pharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Hookipa Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hookipa Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hookipa Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Hookipa Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Hookipa Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Hookipa Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Hookipa Pharma Stock:
Check out Hookipa Pharma Piotroski F Score and Hookipa Pharma Altman Z Score analysis.
For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Hookipa Stock analysis

When running Hookipa Pharma's price analysis, check to measure Hookipa Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hookipa Pharma is operating at the current time. Most of Hookipa Pharma's value examination focuses on studying past and present price action to predict the probability of Hookipa Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hookipa Pharma's price. Additionally, you may evaluate how the addition of Hookipa Pharma to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Hookipa Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.86)
Revenue Per Share
0.213
Quarterly Revenue Growth
(0.05)
Return On Assets
(0.32)
Return On Equity
(0.85)
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.